Open AccessHER2‐positive metastatic, parotid salivary duct carcinoma treated with a trastuzumab/pertuzumab‐based chemotherapy: A case report
Author(s) -
Longo Raffaele,
Legros PierreOlivier,
Talbi Marouane,
Wagner Marc,
Paraschiv ElenaAdinisia,
Campitiello Marco,
Plastino Francesca,
Rozzi Antonio
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3209
Subject(s) - medicine , pertuzumab , salivary duct carcinoma , trastuzumab , chemotherapy , salivary gland , oncology , radiology , pathology , cancer , breast cancer
This case highlights the rare entity, salivary duct carcinoma (SDC), which is difficult to diagnose and manage. It is the first published case of a metastatic, HER2‐positive parotid SDC successfully treated by a dual anti‐HER2 treatment associated to a chemotherapy.